Long-Term Risperidone Treatment Induces Visceral Adiposity Associated with Hepatic Steatosis in Mice: A Magnetic Resonance Approach

Table 2

Experimental parameters analysis.

Data Sets		Control group		Risperidone group		Significance
		𝑛	Mean ± SD	𝑛	Mean ± SD
AUC (mg/dL·120 min)		10	27,453 ± 2,389	10	42,276 ± 12,999	S (𝑃<0.001)
Tissue weight (g)	Liver	12	1.10±0.14	12	1.50±0.17	S (𝑃<0.001)
Tissue volume (mm^3)	Liver	12	635.74±49.54	12	702.77±32.01	S (𝑃<0.01)
	IAT	12	232.40±34.20	12	544.19±127.20	S (𝑃<0.001)
	VAT	12	317.89±116.78	12	1,065.06 ± 383.76	S (𝑃<0.001)